Skip Navigation

This Article
Right arrow Print PDF (5858K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Ball, D. W.
Right arrow Articles by Bustros, A. d.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ball, D. W.
Right arrow Articles by Bustros, A. d.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1992, Vol. 20, No. 1 117-123
© 1992

MOLECULAR BIOLOGY

Human Calcitonin gene regulation by helix-loop-nelix recognition sequences

Douglas W. Ball1, Debra Compton2, Barry D. Nelkin2, Stephen B. Baylin1,2 and Andrée de Bustros1,2

1Department of Medicine, The Johns Hopkins University School of Medicine 424 N. Bond Street, Baltimore, MD 21231, USA 2The Oncology Center, The Johns Hopkins University School of Medicine 424 N. Bond Street, Baltimore, MD 21231, USA

Received August 20, 1991. Revised November 26, 1991. Accepted November 26, 1991.

Human calcitonin (CT) gene transcription is regulated by proximal 5' flanking sequences which mediate cAMP-induced expression, and by a distal basal enhancer region. Using transient expression of CT-CAT constructs, we showed that the basalt enhancer is active in a CT-producing small cell lung cancer cell line (DMS53) and the thyroid C cell derived tumor line, TT, but is inactive in non-CT-producing cell lines. In deletional and direct mutational analyses of the distal enhancer region, disruption of two elements resembling recognition sequences for the helix-loop-helix (HLH) family of transcriptional regulatory proteins resulted in a significant loss of basal transcriptional enhancer action. These results suggest that HLH recognition motifs may mediate a significant portion of constitutive CT gene transcriptional activity in these cells. Nuclear protein extracts from DMS53 cells formed specific binding complexes with oligonucleotides containing two of these candidate enhancer sequences. However, proteins capable of binding to these CT gene HLH consensus recognition sites were not restricted to CT-producing cells. We conclude that members of the HLH protein family, some expressed ubiquitously and some expressed or activated in a tissue-restricted fashion, may combine to enhance CT gene transcription in tumor cells of neuroendocrine derivation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
T. J. Viney, T. W. Schmidt, W. Gierasch, A. W. Sattar, R. E. Yaggie, A. Kuburas, J. P. Quinn, J. M. Coulson, and A. F. Russo
Regulation of the Cell-specific Calcitonin/Calcitonin Gene-related Peptide Enhancer by USF and the Foxa2 Forkhead Protein
J. Biol. Chem., November 26, 2004; 279(48): 49948 - 49955.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
P. L. Durham and A. F. Russo
Stimulation of the Calcitonin Gene-Related Peptide Enhancer by Mitogen-Activated Protein Kinases and Repression by an Antimigraine Drug in Trigeminal Ganglia Neurons
J. Neurosci., February 1, 2003; 23(3): 807 - 815.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. M. Lanigan and A. F. Russo
Binding of Upstream Stimulatory Factor and a Cell-specific Activator to the Calcitonin/Calcitonin Gene-related Peptide Enhancer
J. Biol. Chem., July 18, 1997; 272(29): 18316 - 18324.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Morel, M. Cordier-Bussat, and J. Philippe
The Upstream Promoter Element of the Glucagon Gene, G1, Confers Pancreatic Alpha Cell-specific Expression
J. Biol. Chem., February 17, 1995; 270(7): 3046 - 3055.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.